Biogen’s ‘positive’ Alzheimer’s trial has a problem with small numbers
NATIONAL INSTITUTE ON AGING, NIH
A presentation revealed that BAN2401's glimmer of promise is based on results from a small subset of patients in an otherwise large trial.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario